- conflicts or gaps
- Sold first lead CAR-T IP to Biosceptre in mid-2020; currently raising capital for Phase I/II trial
- raw json
- {"company_name": "Carina Biotech", "founders": [{"name": "Dr Justin Coombs", "role": "Founding CEO / Head of IP and Technology Development", "work_history": "Founded Carina Biotech in 2016 as spin-out of CRC for Cell Therapy Manufacturing", "education": null, "source_urls": ["http://icc.adelaide.edu.au/about/icc-startups-and-residents/carina-biotech/"]}, {"name": "Dr Deborah Rathjen", "role": "CEO and Managing Director", "work_history": "Joined as CEO after Justin Coombs stepped down", "education": null, "source_urls": ["http://icc.adelaide.edu.au/about/icc-startups-and-residents/carina-biotech/"]}], "funding_rounds": [], "headcount_snapshots": [{"date_or_year": "2020", "employee_count": 4, "source_urls": ["http://icc.adelaide.edu.au/about/icc-startups-and-residents/carina-biotech/"]}], "acquisitions": [], "conflicts_or_gaps": "Sold first lead CAR-T IP to Biosceptre in mid-2020; currently raising capital for Phase I/II trial", "overview": {"short_description": "Creating a future that defeats cancer through next-generation CAR-T cell therapies", "hq_location": "Adelaide, South Australia, Australia", "founded_year": 2016, "company_status": "active", "business_model": "Biopharmaceutical CAR-T cell therapy development", "source_urls": ["http://icc.adelaide.edu.au/about/icc-startups-and-residents/carina-biotech/"]}}
- source urls
- ["http://icc.adelaide.edu.au/about/icc-startups-and-residents/carina-biotech/"]